Sitaxsentan-Induced Acute Severe Hepatitis Treated with Glucocorticoid Therapy
Endothelin receptor antagonists are commonly used in the treatment of pulmonary hypertension. Sitaxsentan, a selective endothelin A receptor blocker, induces a mild transaminitis in approximately 3% to 5% of patients, but rarely an acute severe hepatitis. A case involving a 61-year-old female with s...
Main Authors: | Marcus W Chin, Robert D Levy, Eric M Yoshida, Michael F Byrne |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2012/567024 |
Similar Items
-
A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
by: Aaron B Waxman
Published: (2007-03-01) -
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
by: Safdar Z
Published: (2011-03-01) -
Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
by: Eve-Irene Lepist, et al.
Published: (2014-01-01) -
Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade
by: Valerio Zacà, et al.
Published: (2009-02-01) -
Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)